Premia Spine Secures FDA Approval for IDE Study of TOPS

Premia Spine TOPS

Premia Spine secured FDA approval for a pivotal Investigational Device Exemption (IDE) study of the new TOPS™ system, a posterior arthroplasty device for the treatment of degenerative grade I spondylolisthesis and stenosis. The study seeks to establish the superiority of TOPS vs. traditional lumbar spinal fusion.

The IDE study will take place...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us